Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
The Dawn Of Drug Safety
Download The Dawn Of Drug Safety full books in PDF, epub, and Kindle. Read online The Dawn Of Drug Safety ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis The Dawn of Drug Safety by : M. D. B. Stephens
Download or read book The Dawn of Drug Safety written by M. D. B. Stephens and published by . This book was released on 2012-04 with total page 408 pages. Available in PDF, EPUB and Kindle. Book excerpt: This text looks at the safety of drugs from the beginning of time until 1961, including six marker drugs and the problems of 50 drugs subsequently withdrawn or restricted.
Book Synopsis The Dawn of Drug Safety by : M. D. B. Stephens
Download or read book The Dawn of Drug Safety written by M. D. B. Stephens and published by . This book was released on 2010 with total page 426 pages. Available in PDF, EPUB and Kindle. Book excerpt: This text looks at the safety of drugs from the beginning of time until 1961, including six marker drugs and the problems of 50 drugs subsequently withdrawn or restricted.
Author :United States. Congress. House. Committee on Government Operations Publisher : ISBN 13 : Total Pages :842 pages Book Rating :4.3/5 (97 download)
Book Synopsis Drug Safety by : United States. Congress. House. Committee on Government Operations
Download or read book Drug Safety written by United States. Congress. House. Committee on Government Operations and published by . This book was released on 1964 with total page 842 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis The Future of Drug Safety by : Institute of Medicine
Download or read book The Future of Drug Safety written by Institute of Medicine and published by National Academies Press. This book was released on 2007-02-27 with total page 346 pages. Available in PDF, EPUB and Kindle. Book excerpt: In the wake of publicity and congressional attention to drug safety issues, the Food and Drug Administration (FDA) requested the Institute of Medicine assess the drug safety system. The committee reported that a lack of clear regulatory authority, chronic underfunding, organizational problems, and a scarcity of post-approval data about drugs' risks and benefits have hampered the FDA's ability to evaluate and address the safety of prescription drugs after they have reached the market. Noting that resources and therefore efforts to monitor medications' riskâ€"benefit profiles taper off after approval, The Future of Drug Safety offers a broad set of recommendations to ensure that consideration of safety extends from before product approval through the entire time the product is marketed and used.
Author :United States. Congress. House. Committee on Government Operations Publisher : ISBN 13 : Total Pages :1600 pages Book Rating :4.F/5 ( download)
Book Synopsis Drug Safety by : United States. Congress. House. Committee on Government Operations
Download or read book Drug Safety written by United States. Congress. House. Committee on Government Operations and published by . This book was released on 1964 with total page 1600 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Author :United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee Publisher : ISBN 13 : Total Pages :2438 pages Book Rating :4.:/5 (319 download)
Book Synopsis Drug Safety by : United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee
Download or read book Drug Safety written by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee and published by . This book was released on 1964 with total page 2438 pages. Available in PDF, EPUB and Kindle. Book excerpt: Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5.
Download or read book Drug Safety written by Nigel S. B. Rawson and published by FriesenPress. This book was released on 2016-11-08 with total page 274 pages. Available in PDF, EPUB and Kindle. Book excerpt: With "Big Pharma" garnering an increasing number of negative headlines due to reports of adverse drug reactions and a surge in prescription drug addiction and overdose deaths, many people are increasingly skeptical about the safety of modern pharmaceutics and the moral integrity of the pharmaceutical industry. This book was written to provide a balanced perspective on drug safety risks. No therapeutic prescription drug is entirely risk-free. Before receiving marketing approval, new drugs go through arduous and expensive testing processes that can take up to a decade and cost over two billion dollars. While not perfect, the process is far from a "Wild West" environment where big pharmaceutical companies ride roughshod over government regulators. However, author and pharmacoepidemiologist Nigel Rawson argues, the antipathy that is common between governments, pharmaceutical industry and academic experts in Canada needs to change to an environment of collaboration and partnership to enhance our ability to respond in a timely fashion to future pharmaceutical crises. While directed mainly at students in the health sciences and pharmaceutical professionals, this book will be of interest to anyone, including lay people and policy makers, who would like to know more about the evolution of the prescription drug evaluation and risk assessment process. Although the book focuses primarily on Canada, it makes comparisons with the United States and Europe, and several of the author's recommendations for how to improve the prescription drug evaluation process are applicable worldwide.
Book Synopsis Children and Drug Safety by : Cynthia Anne Connolly
Download or read book Children and Drug Safety written by Cynthia Anne Connolly and published by Critical Issues in Health and. This book was released on 2018 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance--many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.
Book Synopsis Improving Drug Safety — A Joint Responsibility by : Rolf Dinkel
Download or read book Improving Drug Safety — A Joint Responsibility written by Rolf Dinkel and published by Springer. This book was released on 1991-02 with total page 368 pages. Available in PDF, EPUB and Kindle. Book excerpt: As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety? In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an "international dialogue conference" by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), the Swiss International Pharmaceutical Agency, and the RAD-AR Consortium. This book documents the papers presented and discussions held at this conference, which took the topic of risks and benefits of drug therapy one step further to responsibility. It includes a rich menu of issues for those who care about the evaluation of drug therapy, the ethics behind it, the expectations of the patient, and the role of traditional and nontraditional drug safety communica tions. The ideas expressed here come from different parts of the world but relate to common drug safety problems, observations, and scientific assessments; they provide insights into innovative approaches, cautious changes, and desired actions. The papers in this volume are broadly divided into conceptual perspectives (ethics, how the knowledge about drug risks and benefits is generated and appraised, the expectations in drug safety) and operational perspectives (communication, discussion, and action).
Book Synopsis Adverse Reactions to Drugs by : O. L. Wade
Download or read book Adverse Reactions to Drugs written by O. L. Wade and published by Elsevier. This book was released on 2013-10-22 with total page 240 pages. Available in PDF, EPUB and Kindle. Book excerpt: Adverse Reactions to Drugs, Second Edition focuses on the problems posed by the adverse responses to drugs, as well as drug interactions, dosage, and drug metabolism. The publication first tackles adverse reactions and factors which predispose to adverse drug reactions. Topics include dose adjustment, overdose, renal failure, cumulation, side effects, drug allergy, cumulative overdose, and delayed effects. The text then ponders on drug interactions, including renal excretion, drug metabolism, mutual toxicity, and interactions affecting transport to site of action. The manuscript examines adverse reactions in dental practice, drugs used in pregnancy, the neonate, and lactation, and problems for the pharmaceutical industry before marketing a new drug. Discussions focus on ethical problems of drug studies in man, pregnancy, hemorrhage, oxygen toxicity, chloramphenicol, drugs and lactation, drugs used in dental practice, and local anesthetics. The book then elaborates on monitoring adverse reactions to drugs and the therapeutic audit and drug regulatory bodies and their problems. The publication is a valuable source of data for doctors and dentists wanting to focus on research on the adverse reaction to drugs.
Book Synopsis The Perception and Management of Drug Safety Risks by : Bruno Horisberger
Download or read book The Perception and Management of Drug Safety Risks written by Bruno Horisberger and published by Springer. This book was released on 1989-01-16 with total page 248 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book represents a collaborative effort by academic experts, members of the pharmaceutical industry, international organizations, and public spokesmen to explore the problems associated with drug risk and drug safety. In an international conference, representatives from 10 countries discussed pharmacology, epidemiology, risk evaluation, regulatory standards, and public communication. Specific topics dealt with include the risk/benefit relationship, biostatistical data interpretation, consumer perception, and proposals for multidisciplinary and international efforts to address challenges in drug safety management.
Book Synopsis Don't Tell the Patient by : William Howard Wallace Inman
Download or read book Don't Tell the Patient written by William Howard Wallace Inman and published by . This book was released on 1999 with total page 312 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Medication Safety by : Henri Richard Manasse
Download or read book Medication Safety written by Henri Richard Manasse and published by ASHP. This book was released on 2005 with total page 394 pages. Available in PDF, EPUB and Kindle. Book excerpt: Medication safety is the most challenging goal for pharmacy practice and patient safety professionals in all health care facilities. This book serves as an essential reference guide for planning and implementing a medication safety program. Written by nationally-recognized experts, Medication Safety: A Guide for Health Care Facilities provides a comprehensive analysis of principles and practices associated with the prevention and identification of medication errors, as well as interdisciplinary, facility-wide recommendations for achieving medication safety in all settings. This book is divided into four sections so users can easily find the information they need: the Importance of Medication Safety, the Medication Safety Team, Building a Safe Medication Use System, and Measuring Medication Safety.
Book Synopsis More than Medicine by : Robert M. Kaplan
Download or read book More than Medicine written by Robert M. Kaplan and published by Harvard University Press. This book was released on 2019-02-01 with total page 241 pages. Available in PDF, EPUB and Kindle. Book excerpt: American science produces the best medical treatments in the world. Yet U.S. citizens lag behind in life expectancy and quality of life. Robert Kaplan marshals extensive data to make the case that U.S. health care priorities are sorely misplaced—invested in attacking disease, not in solving social problems that engender disease in the first place.
Book Synopsis Pharmaceutical Medicine and Translational Clinical Research by : Divya Vohora
Download or read book Pharmaceutical Medicine and Translational Clinical Research written by Divya Vohora and published by Academic Press. This book was released on 2017-11-14 with total page 526 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pharmaceutical Medicine and Translational Clinical Research covers clinical testing of medicines and the translation of pharmaceutical drug research into new medicines, also focusing on the need to understand the safety profile of medicine and the benefit-risk balance. Pharmacoeconomics and the social impact of healthcare on patients and public health are also featured. It is written in a clear and straightforward manner to enable rapid review and assimilation of complex information and contains reader-friendly features. As a greater understanding of these aspects is critical for students in the areas of pharmaceutical medicine, clinical research, pharmacology and pharmacy, as well as professionals working in the pharmaceutical industry, this book is an ideal resource. Includes detailed coverage of current trends and key topics in pharmaceutical medicine, including biosimilars, biobetters, super generics, and Provides a comprehensive look at current and important aspects of the science and regulation of drug and biologics discovery
Book Synopsis An Overview of FDA Regulated Products by : Eunjoo Pacifici
Download or read book An Overview of FDA Regulated Products written by Eunjoo Pacifici and published by Academic Press. This book was released on 2018-06-13 with total page 280 pages. Available in PDF, EPUB and Kindle. Book excerpt: Today’s challenge, especially for many newcomers to the regulated industry, is not necessarily to gather regulatory information, but to know how to interpret and apply it. The ability to discern what is important from what is not, and to interpret regulatory documents correctly, provides a valuable competitive advantage to any newcomer or established professional in this field. An Overview of FDA Regulated Products: From Drugs and Medical Devices to Food and Tobacco provides a valuable summary of the key information to unveil the meaning of critical, and often complex, regulatory concepts. Concise and easy to read with practical explanations, key points, summaries and case studies, this book highlights the regulatory processes involved in bringing an FDA regulated product from research and development to approval and market. Although the primary focus will be on the US system, this book also features global perspectives where appropriate. A valuable resource for students, professors and professionals, An Overview of FDA Regulated Products illustrates the most important elements and concepts so that the reader can focus on the critical issues and make the necessary connections to be successful. Provides an overview of key regulatory requirements using a practical approach that features detailed discussions of hypothetical and real-world case studies in order to highlight the concepts and applications of regulations Covers all FDA regulated products, including drugs, biologics, medical devices, cosmetics, foods, dietary supplements, cosmetics, veterinary products, tobacco and more in one single reference Illustrates complex topics in a clear, succinct and engaging manner by breaking down technical terms and offering straightforward and easy to understand explanations
Author :National Academies of Sciences, Engineering, and Medicine Publisher :National Academies Press ISBN 13 :0309672104 Total Pages :427 pages Book Rating :4.3/5 (96 download)
Book Synopsis Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis by : National Academies of Sciences, Engineering, and Medicine
Download or read book Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2020-04-24 with total page 427 pages. Available in PDF, EPUB and Kindle. Book excerpt: Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.
